Skip Navigation

Estrogen not associated with lung cancer incidence and mortality among postmenopausal women

16 August 2010

Use of estrogen alone did not increase lung cancer mortality in postmenopausal women, according to a study published online 13 August in The Journal of the National Cancer Institute.

In the Women’s Health Initiative (WHI) trial, which consisted of several clinical trials on postmenopausal women, one study showed women with previous hysterectomy taking combined estrogen plus progestin therapy had a statistically significant increase in lung cancer mortality, but not incidence. Other studies with combined hormone therapy have had conflicting results. But the influence of estrogen alone was unclear.

Read the abstract here.

Published in The Journal of the National Cancer Institute, Advanced Access, 13 August 2010.

Read the full press release here.



In the news

Reuters - Estrogen-only therapy may not up lung cancer deaths

Business Week - No Evidence Estrogen Causes Lung Cancer Post-Hysterectomy